InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Dentzer James E, Chairman & CEO. Insider active across 2 companies, notably CURIS INC. Aggregated, 5 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €7k. Activity tracked since 27 January 2022. The latest transaction was filed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Dentzer James E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,934 shares@ US$1.590.13% mcap16.8% of flowCommon StockSEC:0001437749-26-025667:0
11,148 shares@ US$2.20100.0% of flowCommon StockSEC:0001437749-26-018549:0
133,333 sharesCommon StockSEC:0001108205-26-000037:0
3,318 shares@ US$9.2055.5% of flowCommon StockSEC:0001437749-25-025102:0
2,406 shares@ US$3.18100.0% of flowCommon StockSEC:0001209191-22-005651:0
5 of 5 declarations
About Dentzer James E
Dentzer James E is President & CEO and has 5 filings in total. Across the 5 most recent sampled filings, there were 0 in buys and 6805 in sells, between 2022-01-31 and 2026-08-04. The listed companies are Imunon, Inc. and CURIS INC, and the modal transaction nature is Attribution.
